Yes there will be challenges, not the least of which will be cost concerns, but immunotherapy is coming of age in cancer treatment, said experts at the 2015 Forbes Healthcare Summit.
from Forbes – Tech http://ift.tt/1XNlMC8
via IFTTT
Yes there will be challenges, not the least of which will be cost concerns, but immunotherapy is coming of age in cancer treatment, said experts at the 2015 Forbes Healthcare Summit.
from Forbes – Tech http://ift.tt/1XNlMC8
via IFTTT